UBS Group AG - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$97,909
+3.8%
33,416
+1.3%
0.00%
Q2 2023$94,331
+48.3%
32,983
+60.2%
0.00%
Q1 2023$63,605
+868.0%
20,584
+561.0%
0.00%
Q4 2022$6,571
-79.5%
3,114
-68.3%
0.00%
Q3 2022$32,000
+100.0%
9,827
+92.0%
0.00%
Q2 2022$16,000
-99.1%
5,117
-97.9%
0.00%
-100.0%
Q4 2021$1,750,000
+19344.4%
241,374
+30924.9%
0.00%
Q3 2021$9,0007780.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders